Evidence map›Paper›PMID 39728283›Full record

ArticleJournal of cardiovascular development and disease2024

Percutaneous Embolization of No Ligated Vertical Veins After Total Anomalous Pulmonary Vein Return Operation and Risk Factors for Its Persistence.

Stasa Krasic, Sofija Popovic, Vesna Topic, Mila Stajevic, Ivan Dizdarevic, Sasa Popovic, Dejan Nesic, Vladislav Vukomanovic

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cardiovascular development and disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Stasa KrasicCardiology Department, Mother and Child Health Institute of Serbia, 11070 Belgrade, Serbia.ORCID 0000-0002-3007-5631
Sofija PopovicCardiology Department, Mother and Child Health Institute of Serbia, 11070 Belgrade, Serbia.
Vesna TopicRadiology Department, Mother and Child Health Institute of Serbia, 11070 Belgrade, Serbia.
Mila StajevicFaculty of Medicine, University of Belgrade, 11129 Belgrade, Serbia.
Ivan DizdarevicCardiac Surgery Department, Mother and Child Health Institute of Serbia, 11070 Belgrade, Serbia.
Sasa PopovicCardiology Department, Mother and Child Health Institute of Serbia, 11070 Belgrade, Serbia.
Dejan NesicInstitute of Medical Physiology, Faculty of Medicine, University of Belgrade, Visegradska 26/II, 11129 Belgrade, Serbia.
Vladislav VukomanovicCardiology Department, Mother and Child Health Institute of Serbia, 11070 Belgrade, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe vertical vein (VV) ligation during the total anomalous pulmonary venous return (TAPVR) correction is still controversial. Our study aimed to define the potential risk factors for VV persistence and their percutaneous occlusion.

methodsThe retrospective cohort study included 40 patients (26 males) with TAPVR treated at the tertiary referral center from 2005 to 2024.

resultsThe average days of age at diagnosis was two (IQR 1-8). Complex congenital heart disease with TAPVR was diagnosed in eight patients. A supracardiac type of TAPVR was found in 47% of them. The patients underwent the operation on their eighth day of life (IQR 5-57). The follow-up period was 32 months (IQR 8-99). The early postoperative mortality rate was 17.5%, significantly frequent in the patients' group with combined CHD (

conclusionsWe found that an LA diameter Z score of lower than -4 was a major risk factor for VV persistence. Percutaneous VV embolization is a safe and effective procedure in adolescents.

Indexed as

left atrium diameterpercutaneous embolizationtotal anomalous pulmonary venous returnvertical vein

Identifiers

PMID39728283
PMCPMC11676295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.